©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7708-7719
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7708
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7708
Table 3 Postoperative complications, recurrence, metastasis, and mortality (n = 307)
| Variables | Median (range) / n (%) |
| Clavien-Dindo stage | |
| None | 109 (35.5%) |
| I | 27 (8.8%) |
| II | 121 (39.4%) |
| IIIa | 28 (9.1%) |
| IIIb | 4 (1.3%) |
| IV | 4 (1.3%) |
| IVa | 8 (2.6%) |
| IVb | 6 (2.0%) |
| CCI, median (range) | 20.9 (0, 96.6) |
| Anastomotic leakage | 75 (24.4%) |
| Secondary operation | 7 (2.3%) |
| Hypoalbuminemia | 88 (28.7%) |
| Pulmonary infection | 68 (22.1%) |
| Recurrence | 11 (3.6%) |
| Metastasis | 21 (6.8%) |
| In-hospital mortality | 52 (16.9%) |
| 30-day mortality | 61 (19.9%) |
| 90-day mortality | 78 (25.4%) |
- Citation: Shi MK, Mei YQ, Shi JL. Short- (30-90 days) and mid-term (1-3 years) outcomes and prognostic factors of patients with esophageal cancer undergoing surgical treatments. World J Clin Cases 2022; 10(22): 7708-7719
- URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7708.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i22.7708